Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/26/2015 01/27/2015 01/28/2015 01/29/2015 01/30/2015 Date
125.12(c) 123.67(c) 121.26(c) 114.14(c) 110.14 Last
1 203 838 1 103 818 1 830 552 4 027 048 2 958 611 Volume
-0.36% -1.16% -1.95% -5.87% -3.50% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs.The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
05/05Earnings Release
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2015 1 135 M
EBIT 2015 -196 M
Net income 2015 -299 M
Finance 2015 570 M
Yield 2015 -
Sales 2016 2 882 M
EBIT 2016 1 333 M
Net income 2016 1 055 M
Finance 2016 1 790 M
Yield 2016 -
PER 2015 -
PER 2016 29,57
EV / Sales 2015 23,7x
EV / Sales 2016 8,91x
Capitalization 27 453 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
01/28 VERTEX PHARMACEUTICALS : 4Q loss is deeper than expected
01/28 VERTEX PHARMACEUTICALS : Reports Full-Year and Fourth Quarter 2014 Financial Res..
01/14 VERTEX PHARMACEUTICALS : Announces Upcoming Presentation at the J.P. Morgan Heal..
01/11 VERTEX PHARMACEUTICALS : Pharma Expects 2015 Kalydeco Revenues Of $560 Mln To $5..
01/11 VERTEX PHARMACEUTICALS : Outlines 2015 Business Priorities
01/11 VERTEX PHARMACEUTICALS : Outlines 2015 Business Priorities to Support the Develo..
01/08 VERTEX PHARMACEUTICALS : Reports Summarize Magnetic Resonance Research Findings ..
01/08 VERTEX PHARMACEUTICALS : U.S. Food and Drug Administration Approves KALYDECO® iv..
More news
Sector news Biopharmaceuticals
04:17pDJAbbVie Hepatitis C Drug Predictions Disappoint -- Update
02:41p SALIX PHARMACEUTICALS : Federman & Sherwood : Investigates Salix Pharmaceuticals..
02:35p RANBAXY LABORATORIES : FTC clears Sun Pharma's $4B purchase of competitor Ranbax..
Plus d'actualités du secteur Biopharmaceuticals


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF